Rank | Gene Set | Z-score |
---|---|---|
1 | sarcomere organization (GO:0045214) | 6.36817531 |
2 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.05281287 |
3 | cardiac myofibril assembly (GO:0055003) | 5.99443778 |
4 | * actin-myosin filament sliding (GO:0033275) | 5.96889857 |
5 | * muscle filament sliding (GO:0030049) | 5.96889857 |
6 | * myofibril assembly (GO:0030239) | 5.48984535 |
7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.34261768 |
8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.21264464 |
9 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.15244141 |
10 | * actin-mediated cell contraction (GO:0070252) | 5.08782564 |
11 | axon ensheathment in central nervous system (GO:0032291) | 5.07340420 |
12 | central nervous system myelination (GO:0022010) | 5.07340420 |
13 | regulation of relaxation of muscle (GO:1901077) | 5.07215744 |
14 | regulation of actin filament-based movement (GO:1903115) | 4.96294725 |
15 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.94310556 |
16 | negative regulation of protein localization to cell surface (GO:2000009) | 4.92769983 |
17 | cardiac muscle contraction (GO:0060048) | 4.86817733 |
18 | regulation of cell communication by electrical coupling (GO:0010649) | 4.84076682 |
19 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.80544600 |
20 | regulation of skeletal muscle contraction (GO:0014819) | 4.68793840 |
21 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.54734395 |
22 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.52782544 |
23 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.43188874 |
24 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.39363789 |
25 | regulation of sarcomere organization (GO:0060297) | 4.31750448 |
26 | striated muscle contraction (GO:0006941) | 4.28726302 |
27 | heart contraction (GO:0060047) | 4.24666395 |
28 | heart process (GO:0003015) | 4.24666395 |
29 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.23399030 |
30 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.21286291 |
31 | regulation of striated muscle contraction (GO:0006942) | 4.20110427 |
32 | * actomyosin structure organization (GO:0031032) | 4.20023808 |
33 | creatine metabolic process (GO:0006600) | 4.13661497 |
34 | cardiac muscle cell development (GO:0055013) | 4.12320391 |
35 | adult heart development (GO:0007512) | 4.12245596 |
36 | muscle tissue morphogenesis (GO:0060415) | 4.10781284 |
37 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.07105540 |
38 | regulation of membrane repolarization (GO:0060306) | 4.04744069 |
39 | plasma membrane repair (GO:0001778) | 3.94117152 |
40 | cardiac muscle hypertrophy (GO:0003300) | 3.91102821 |
41 | cardiac cell development (GO:0055006) | 3.90348682 |
42 | heart trabecula formation (GO:0060347) | 3.78637094 |
43 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.78202690 |
44 | relaxation of cardiac muscle (GO:0055119) | 3.77895325 |
45 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.76124417 |
46 | striated muscle hypertrophy (GO:0014897) | 3.74955960 |
47 | respiratory electron transport chain (GO:0022904) | 3.70829669 |
48 | * actin filament-based movement (GO:0030048) | 3.69145371 |
49 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.68130855 |
50 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.62983859 |
51 | electron transport chain (GO:0022900) | 3.61160542 |
52 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.58763247 |
53 | ATP synthesis coupled proton transport (GO:0015986) | 3.58763247 |
54 | relaxation of muscle (GO:0090075) | 3.58544479 |
55 | oxygen transport (GO:0015671) | 3.54877177 |
56 | striated muscle adaptation (GO:0014888) | 3.52863391 |
57 | NADH metabolic process (GO:0006734) | 3.51918852 |
58 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.51344805 |
59 | gas transport (GO:0015669) | 3.49766635 |
60 | response to inactivity (GO:0014854) | 3.49721392 |
61 | regulation of cardiac muscle contraction (GO:0055117) | 3.49632841 |
62 | cell communication involved in cardiac conduction (GO:0086065) | 3.49166092 |
63 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.47413682 |
64 | regulation of cardioblast differentiation (GO:0051890) | 3.45516107 |
65 | regulation of ATPase activity (GO:0043462) | 3.40139184 |
66 | regulation of ATP catabolic process (GO:1903289) | 3.40139184 |
67 | skeletal muscle contraction (GO:0003009) | 3.38692715 |
68 | tricarboxylic acid cycle (GO:0006099) | 3.36628594 |
69 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.36266196 |
70 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.36266196 |
71 | glucan biosynthetic process (GO:0009250) | 3.35911936 |
72 | glycogen biosynthetic process (GO:0005978) | 3.35911936 |
73 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.30766760 |
74 | carnitine shuttle (GO:0006853) | 3.30708098 |
75 | skeletal muscle adaptation (GO:0043501) | 3.30436887 |
76 | succinate metabolic process (GO:0006105) | 3.29739852 |
77 | regulation of the force of heart contraction (GO:0002026) | 3.25968498 |
78 | muscle hypertrophy (GO:0014896) | 3.25064838 |
79 | glycogen catabolic process (GO:0005980) | 3.21255448 |
80 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.18392136 |
81 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.17306465 |
82 | axon ensheathment (GO:0008366) | 3.15857296 |
83 | ensheathment of neurons (GO:0007272) | 3.15857296 |
84 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.15059774 |
85 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.15020846 |
86 | response to muscle activity (GO:0014850) | 3.14628227 |
87 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.13474789 |
88 | myelination (GO:0042552) | 3.13138950 |
89 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.10571993 |
90 | muscle fiber development (GO:0048747) | 3.09911271 |
91 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.09552969 |
92 | regulation of heart rate (GO:0002027) | 3.09444478 |
93 | detection of calcium ion (GO:0005513) | 3.08222968 |
94 | cellular response to epinephrine stimulus (GO:0071872) | 3.05270239 |
95 | positive regulation of potassium ion transport (GO:0043268) | 3.04820899 |
96 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.02527481 |
97 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.02251514 |
98 | response to epinephrine (GO:0071871) | 3.01569753 |
99 | skeletal muscle fiber development (GO:0048741) | 2.99389552 |
100 | cardiac conduction (GO:0061337) | 2.98907828 |
101 | positive regulation of sodium ion transport (GO:0010765) | 2.98730368 |
102 | cardiac muscle cell action potential (GO:0086001) | 2.98235403 |
103 | glucan catabolic process (GO:0009251) | 2.97671498 |
104 | muscle contraction (GO:0006936) | 2.97495927 |
105 | cardiac chamber formation (GO:0003207) | 2.96181255 |
106 | myotube cell development (GO:0014904) | 2.96061994 |
107 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.94818737 |
108 | positive regulation of action potential (GO:0045760) | 2.94753478 |
109 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.91153864 |
110 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.91153864 |
111 | cell communication by electrical coupling (GO:0010644) | 2.90647367 |
112 | regulation of heart contraction (GO:0008016) | 2.89818992 |
113 | negative regulation of potassium ion transport (GO:0043267) | 2.88904290 |
114 | muscle cell fate commitment (GO:0042693) | 2.86641314 |
115 | regulation of muscle contraction (GO:0006937) | 2.85353259 |
116 | potassium ion import (GO:0010107) | 2.85027756 |
117 | fatty acid transmembrane transport (GO:1902001) | 2.84668066 |
118 | cardiac ventricle formation (GO:0003211) | 2.83462595 |
119 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.83023443 |
120 | regulation of muscle system process (GO:0090257) | 2.82926867 |
121 | neuronal action potential propagation (GO:0019227) | 2.82126859 |
122 | striated muscle cell development (GO:0055002) | 2.79922642 |
123 | regulation of cation channel activity (GO:2001257) | 2.79324665 |
124 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.78814893 |
125 | muscle system process (GO:0003012) | 2.76467456 |
126 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.74457565 |
127 | muscle hypertrophy in response to stress (GO:0003299) | 2.74457565 |
128 | cardiac muscle adaptation (GO:0014887) | 2.74457565 |
129 | positive regulation of cation channel activity (GO:2001259) | 2.73387923 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.49710778 |
2 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.98820866 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.67256247 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.52832166 |
5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.43074878 |
6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.36812202 |
7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.22174380 |
8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.22174380 |
9 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.20540376 |
10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.18483974 |
11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.17697999 |
12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.16305627 |
13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.11350279 |
14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10559586 |
15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.02604420 |
16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95716986 |
17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.95141647 |
18 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.88684693 |
19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.87812865 |
20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.85627149 |
21 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.84227647 |
22 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.82577218 |
23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.82278714 |
24 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.81297151 |
25 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.76029431 |
26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.75624025 |
27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72962012 |
28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71402265 |
29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.69819174 |
30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61629295 |
31 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.60439654 |
32 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.60439654 |
33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58175715 |
34 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57617660 |
35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.54637006 |
36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.53363938 |
37 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.52668375 |
38 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.51300374 |
39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.43748101 |
40 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.41311044 |
41 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40491668 |
42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40304520 |
43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.40001165 |
44 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.37234292 |
45 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.36262493 |
46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35325663 |
47 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.32189042 |
48 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.32151477 |
49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29674245 |
50 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29058982 |
51 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.26034871 |
52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25899155 |
53 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.25794824 |
54 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24305346 |
55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24140243 |
56 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.23989633 |
57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23826646 |
58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23666696 |
59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20825385 |
60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20032699 |
61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19605992 |
62 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19025102 |
63 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17846696 |
64 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.15799083 |
65 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15120801 |
66 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15073821 |
67 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14700028 |
68 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.14179364 |
69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13130646 |
70 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13049924 |
71 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.12248414 |
72 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08949316 |
73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08795319 |
74 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08501224 |
75 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08116596 |
76 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07712204 |
77 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06584390 |
78 | NFYB_21822215_ChIP-Seq_K562_Human | 1.06470713 |
79 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05865488 |
80 | P300_19829295_ChIP-Seq_ESCs_Human | 1.04108575 |
81 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03945119 |
82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03593832 |
83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03593832 |
84 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01499409 |
85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00066444 |
86 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.00031136 |
87 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98902421 |
88 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98168715 |
89 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98160882 |
90 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98125998 |
91 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97873752 |
92 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.97868015 |
93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97490541 |
94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97273171 |
95 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.97142377 |
96 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96878228 |
97 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.96649850 |
98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96087881 |
99 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95971541 |
100 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.95885125 |
101 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.95273243 |
102 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94861070 |
103 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94555006 |
104 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.94480013 |
105 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94205441 |
106 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94090176 |
107 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93492189 |
108 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93396231 |
109 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93044624 |
110 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92253316 |
111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91970170 |
112 | TBL1_22424771_ChIP-Seq_293T_Human | 0.91536814 |
113 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.91040398 |
114 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90605888 |
115 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90605888 |
116 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90306064 |
117 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.90057015 |
118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89139224 |
119 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.88469532 |
120 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.88439535 |
121 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88359627 |
122 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88344078 |
123 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.86584423 |
124 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.85113097 |
125 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.85040571 |
126 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.85015554 |
127 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81583570 |
128 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.80861017 |
129 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.79396508 |
130 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.79033239 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 4.93812862 |
2 | MP0004084_abnormal_cardiac_muscle | 4.34826621 |
3 | MP0000749_muscle_degeneration | 4.32277964 |
4 | MP0000751_myopathy | 4.18604327 |
5 | MP0004036_abnormal_muscle_relaxation | 3.98069207 |
6 | MP0003646_muscle_fatigue | 3.63772954 |
7 | MP0004145_abnormal_muscle_electrophysio | 3.53474548 |
8 | MP0004215_abnormal_myocardial_fiber | 3.45150971 |
9 | MP0005330_cardiomyopathy | 2.97808997 |
10 | * MP0002972_abnormal_cardiac_muscle | 2.58522903 |
11 | MP0005620_abnormal_muscle_contractility | 2.53070331 |
12 | MP0003137_abnormal_impulse_conducting | 2.51747933 |
13 | * MP0004087_abnormal_muscle_fiber | 2.49705187 |
14 | MP0003950_abnormal_plasma_membrane | 2.43165643 |
15 | MP0000747_muscle_weakness | 2.35527465 |
16 | MP0002106_abnormal_muscle_physiology | 2.32334992 |
17 | MP0008775_abnormal_heart_ventricle | 2.31670088 |
18 | MP0004270_analgesia | 2.15372753 |
19 | MP0004147_increased_porphyrin_level | 2.09075626 |
20 | MP0000920_abnormal_myelination | 1.99416722 |
21 | MP0004484_altered_response_of | 1.99000701 |
22 | * MP0004085_abnormal_heartbeat | 1.96188203 |
23 | MP0005369_muscle_phenotype | 1.94546601 |
24 | MP0002269_muscular_atrophy | 1.93878266 |
25 | MP0000759_abnormal_skeletal_muscle | 1.93022581 |
26 | MP0001485_abnormal_pinna_reflex | 1.92631971 |
27 | MP0001544_abnormal_cardiovascular_syste | 1.87442440 |
28 | MP0005385_cardiovascular_system_phenoty | 1.87442440 |
29 | MP0006138_congestive_heart_failure | 1.80207967 |
30 | * MP0010630_abnormal_cardiac_muscle | 1.68198057 |
31 | MP0000750_abnormal_muscle_regeneration | 1.68065402 |
32 | MP0004130_abnormal_muscle_cell | 1.62717308 |
33 | MP0002735_abnormal_chemical_nociception | 1.62138099 |
34 | MP0003880_abnormal_central_pattern | 1.60084768 |
35 | MP0002272_abnormal_nervous_system | 1.51921868 |
36 | MP0003828_pulmonary_edema | 1.47880507 |
37 | MP0004043_abnormal_pH_regulation | 1.45754402 |
38 | MP0002822_catalepsy | 1.44803014 |
39 | MP0006036_abnormal_mitochondrial_physio | 1.44455132 |
40 | MP0005171_absent_coat_pigmentation | 1.40465801 |
41 | MP0004859_abnormal_synaptic_plasticity | 1.37339563 |
42 | MP0003221_abnormal_cardiomyocyte_apopto | 1.36727247 |
43 | MP0004510_myositis | 1.35212902 |
44 | MP0002638_abnormal_pupillary_reflex | 1.29264289 |
45 | MP0002734_abnormal_mechanical_nocicepti | 1.26336396 |
46 | MP0001486_abnormal_startle_reflex | 1.25595547 |
47 | MP0001529_abnormal_vocalization | 1.25299648 |
48 | MP0002127_abnormal_cardiovascular_syste | 1.23179782 |
49 | MP0001661_extended_life_span | 1.19855540 |
50 | MP0004233_abnormal_muscle_weight | 1.18313993 |
51 | MP0003879_abnormal_hair_cell | 1.16771837 |
52 | MP0002909_abnormal_adrenal_gland | 1.15136009 |
53 | MP0005266_abnormal_metabolism | 1.14786702 |
54 | MP0002332_abnormal_exercise_endurance | 1.13445756 |
55 | MP0003656_abnormal_erythrocyte_physiolo | 1.13109323 |
56 | MP0003878_abnormal_ear_physiology | 1.12598317 |
57 | MP0005377_hearing/vestibular/ear_phenot | 1.12598317 |
58 | MP0005646_abnormal_pituitary_gland | 1.07139837 |
59 | MP0002078_abnormal_glucose_homeostasis | 1.06586273 |
60 | MP0002064_seizures | 1.05333428 |
61 | MP0009745_abnormal_behavioral_response | 1.05043306 |
62 | MP0001905_abnormal_dopamine_level | 1.03232051 |
63 | MP0008569_lethality_at_weaning | 1.01746268 |
64 | MP0003787_abnormal_imprinting | 0.98566531 |
65 | MP0001968_abnormal_touch/_nociception | 0.97913360 |
66 | MP0009046_muscle_twitch | 0.96976802 |
67 | MP0003635_abnormal_synaptic_transmissio | 0.96080521 |
68 | MP0002971_abnormal_brown_adipose | 0.95861283 |
69 | MP0004142_abnormal_muscle_tone | 0.95585672 |
70 | MP0005423_abnormal_somatic_nervous | 0.95344472 |
71 | MP0001970_abnormal_pain_threshold | 0.94733751 |
72 | MP0002229_neurodegeneration | 0.93713545 |
73 | MP0005451_abnormal_body_composition | 0.93145368 |
74 | MP0005386_behavior/neurological_phenoty | 0.92683635 |
75 | MP0004924_abnormal_behavior | 0.92683635 |
76 | MP0001502_abnormal_circadian_rhythm | 0.92623548 |
77 | MP0001963_abnormal_hearing_physiology | 0.91837258 |
78 | MP0002067_abnormal_sensory_capabilities | 0.90619523 |
79 | MP0005645_abnormal_hypothalamus_physiol | 0.86368282 |
80 | MP0000003_abnormal_adipose_tissue | 0.86323341 |
81 | MP0002736_abnormal_nociception_after | 0.86006953 |
82 | MP0003329_amyloid_beta_deposits | 0.85977224 |
83 | MP0005535_abnormal_body_temperature | 0.85520429 |
84 | MP0004742_abnormal_vestibular_system | 0.85289638 |
85 | MP0001299_abnormal_eye_distance/ | 0.84180913 |
86 | MP0005670_abnormal_white_adipose | 0.82903417 |
87 | MP0003634_abnormal_glial_cell | 0.82708464 |
88 | MP0003045_fibrosis | 0.82302309 |
89 | MP0001984_abnormal_olfaction | 0.82025886 |
90 | MP0003136_yellow_coat_color | 0.81235512 |
91 | MP0002693_abnormal_pancreas_physiology | 0.79604151 |
92 | MP0005623_abnormal_meninges_morphology | 0.79351557 |
93 | MP0008260_abnormal_autophagy | 0.78584679 |
94 | MP0002733_abnormal_thermal_nociception | 0.78532767 |
95 | MP0003690_abnormal_glial_cell | 0.77307341 |
96 | MP0002108_abnormal_muscle_morphology | 0.76688256 |
97 | MP0000230_abnormal_systemic_arterial | 0.75860202 |
98 | MP0003011_delayed_dark_adaptation | 0.75429399 |
99 | MP0001944_abnormal_pancreas_morphology | 0.73665272 |
100 | MP0004885_abnormal_endolymph | 0.73445967 |
101 | MP0000026_abnormal_inner_ear | 0.73409274 |
102 | MP0005375_adipose_tissue_phenotype | 0.70963457 |
103 | MP0005332_abnormal_amino_acid | 0.69763629 |
104 | MP0000733_abnormal_muscle_development | 0.69186795 |
105 | MP0005379_endocrine/exocrine_gland_phen | 0.69178693 |
106 | MP0003195_calcinosis | 0.69158842 |
107 | MP0002066_abnormal_motor_capabilities/c | 0.68911559 |
108 | MP0006276_abnormal_autonomic_nervous | 0.68043733 |
109 | MP0003122_maternal_imprinting | 0.67487551 |
110 | MP0001440_abnormal_grooming_behavior | 0.67298171 |
111 | MP0009780_abnormal_chondrocyte_physiolo | 0.66978297 |
112 | MP0002063_abnormal_learning/memory/cond | 0.66601706 |
113 | MP0002882_abnormal_neuron_morphology | 0.66395242 |
114 | MP0003123_paternal_imprinting | 0.65635453 |
115 | MP0000778_abnormal_nervous_system | 0.65551688 |
116 | MP0003633_abnormal_nervous_system | 0.65214276 |
117 | MP0003283_abnormal_digestive_organ | 0.64963955 |
118 | MP0003567_abnormal_fetal_cardiomyocyte | 0.62863603 |
119 | MP0005165_increased_susceptibility_to | 0.62675552 |
120 | MP0002572_abnormal_emotion/affect_behav | 0.62504638 |
121 | * MP0000266_abnormal_heart_morphology | 0.61812003 |
122 | MP0005409_darkened_coat_color | 0.61425315 |
123 | MP0000372_irregular_coat_pigmentation | 0.61391466 |
124 | MP0006035_abnormal_mitochondrial_morpho | 0.60654872 |
125 | MP0000013_abnormal_adipose_tissue | 0.59674149 |
126 | MP0000955_abnormal_spinal_cord | 0.59469401 |
127 | MP0002752_abnormal_somatic_nervous | 0.59326090 |
128 | MP0005636_abnormal_mineral_homeostasis | 0.57850599 |
129 | MP0000762_abnormal_tongue_morphology | 0.57578833 |
130 | MP0005448_abnormal_energy_balance | 0.54168586 |
131 | MP0002163_abnormal_gland_morphology | 0.53464838 |
132 | MP0001756_abnormal_urination | 0.53261773 |
133 | MP0005666_abnormal_adipose_tissue | 0.53243965 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 6.42789469 |
2 | Calf muscle hypertrophy (HP:0008981) | 6.15076304 |
3 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.13970870 |
4 | Exercise-induced myalgia (HP:0003738) | 5.90110028 |
5 | Exercise-induced muscle cramps (HP:0003710) | 5.80640451 |
6 | Muscle fiber splitting (HP:0003555) | 5.35478465 |
7 | Hyporeflexia of lower limbs (HP:0002600) | 5.10428207 |
8 | Atrial fibrillation (HP:0005110) | 4.87980655 |
9 | Abnormality of the calf musculature (HP:0001430) | 4.86000569 |
10 | Ventricular tachycardia (HP:0004756) | 4.61402576 |
11 | Primary atrial arrhythmia (HP:0001692) | 4.50452616 |
12 | Subaortic stenosis (HP:0001682) | 4.39841622 |
13 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.39841622 |
14 | Supraventricular tachycardia (HP:0004755) | 4.30863567 |
15 | EMG: myopathic abnormalities (HP:0003458) | 4.21430530 |
16 | Supraventricular arrhythmia (HP:0005115) | 4.19090808 |
17 | Prolonged QT interval (HP:0001657) | 4.01556522 |
18 | Syncope (HP:0001279) | 3.98002830 |
19 | Lipoatrophy (HP:0100578) | 3.91364445 |
20 | Myopathic facies (HP:0002058) | 3.84336454 |
21 | Myoglobinuria (HP:0002913) | 3.79141909 |
22 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.64998850 |
23 | Muscle fiber inclusion bodies (HP:0100299) | 3.62707795 |
24 | Dilated cardiomyopathy (HP:0001644) | 3.58390722 |
25 | Nemaline bodies (HP:0003798) | 3.34830591 |
26 | Myotonia (HP:0002486) | 3.31311236 |
27 | Pheochromocytoma (HP:0002666) | 3.30327425 |
28 | Difficulty running (HP:0009046) | 3.22641317 |
29 | Acute necrotizing encephalopathy (HP:0006965) | 3.21893490 |
30 | Bundle branch block (HP:0011710) | 3.21006874 |
31 | Ventricular arrhythmia (HP:0004308) | 3.16816537 |
32 | Palpitations (HP:0001962) | 3.16654060 |
33 | Ulnar deviation of the wrist (HP:0003049) | 3.12045721 |
34 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.02792994 |
35 | Abnormality of the foot musculature (HP:0001436) | 2.96449984 |
36 | Neuroendocrine neoplasm (HP:0100634) | 2.95976819 |
37 | Foot dorsiflexor weakness (HP:0009027) | 2.94326604 |
38 | Neck muscle weakness (HP:0000467) | 2.91186339 |
39 | Ventricular fibrillation (HP:0001663) | 2.90720277 |
40 | Abnormal EKG (HP:0003115) | 2.89948761 |
41 | Right ventricular cardiomyopathy (HP:0011663) | 2.88309908 |
42 | Asymmetric septal hypertrophy (HP:0001670) | 2.87854339 |
43 | Muscle stiffness (HP:0003552) | 2.84687600 |
44 | Type 1 muscle fiber predominance (HP:0003803) | 2.79833684 |
45 | Frequent falls (HP:0002359) | 2.65437400 |
46 | Progressive macrocephaly (HP:0004481) | 2.65302738 |
47 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.65109866 |
48 | Absent phalangeal crease (HP:0006109) | 2.64284980 |
49 | Left ventricular hypertrophy (HP:0001712) | 2.63293086 |
50 | Mitochondrial inheritance (HP:0001427) | 2.63199514 |
51 | Heart block (HP:0012722) | 2.60564831 |
52 | Rhabdomyolysis (HP:0003201) | 2.60369751 |
53 | Acute encephalopathy (HP:0006846) | 2.58999336 |
54 | Fetal akinesia sequence (HP:0001989) | 2.56795114 |
55 | Calcaneovalgus deformity (HP:0001848) | 2.52716313 |
56 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.50244752 |
57 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.50244752 |
58 | Hyperglycemia (HP:0003074) | 2.48687638 |
59 | Hepatic necrosis (HP:0002605) | 2.47819990 |
60 | Myokymia (HP:0002411) | 2.45648429 |
61 | Hepatocellular necrosis (HP:0001404) | 2.43143894 |
62 | Abnormal atrioventricular conduction (HP:0005150) | 2.42731120 |
63 | Gowers sign (HP:0003391) | 2.42657566 |
64 | Hypoglycemic coma (HP:0001325) | 2.40498603 |
65 | Diaphragmatic weakness (HP:0009113) | 2.39134819 |
66 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.36667271 |
67 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.29316005 |
68 | Ketoacidosis (HP:0001993) | 2.29056382 |
69 | Increased CSF lactate (HP:0002490) | 2.27919316 |
70 | Distal lower limb muscle weakness (HP:0009053) | 2.25089581 |
71 | Hypoplastic ischia (HP:0003175) | 2.21567956 |
72 | Deformed tarsal bones (HP:0008119) | 2.20962631 |
73 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.20398630 |
74 | Areflexia of lower limbs (HP:0002522) | 2.20100544 |
75 | Increased connective tissue (HP:0009025) | 2.17516276 |
76 | Hyperkalemia (HP:0002153) | 2.17132254 |
77 | Atrioventricular block (HP:0001678) | 2.16807229 |
78 | Increased serum pyruvate (HP:0003542) | 2.13765615 |
79 | Abnormality of glycolysis (HP:0004366) | 2.13765615 |
80 | Steppage gait (HP:0003376) | 2.13234034 |
81 | Distal arthrogryposis (HP:0005684) | 2.12009424 |
82 | Malignant hyperthermia (HP:0002047) | 2.10866187 |
83 | Leukodystrophy (HP:0002415) | 2.10535432 |
84 | Abnormal finger flexion creases (HP:0006143) | 2.10479812 |
85 | Increased variability in muscle fiber diameter (HP:0003557) | 2.10169213 |
86 | Late onset (HP:0003584) | 2.10098076 |
87 | Hypoglycemic seizures (HP:0002173) | 2.09524307 |
88 | Palmoplantar keratoderma (HP:0000982) | 2.06146937 |
89 | Exercise intolerance (HP:0003546) | 2.04298283 |
90 | Abnormality of the ischium (HP:0003174) | 2.04196637 |
91 | Round ear (HP:0100830) | 2.01148582 |
92 | Respiratory failure (HP:0002878) | 1.98157815 |
93 | Double outlet right ventricle (HP:0001719) | 1.96343242 |
94 | Congenital malformation of the right heart (HP:0011723) | 1.96343242 |
95 | Hypoplastic left heart (HP:0004383) | 1.94830706 |
96 | Scapular winging (HP:0003691) | 1.94731856 |
97 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.94144536 |
98 | Proximal amyotrophy (HP:0007126) | 1.93936500 |
99 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.93777784 |
100 | Ragged-red muscle fibers (HP:0003200) | 1.90738140 |
101 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.89751630 |
102 | Bradycardia (HP:0001662) | 1.86286702 |
103 | Cerebral hemorrhage (HP:0001342) | 1.86005233 |
104 | Focal motor seizures (HP:0011153) | 1.85643540 |
105 | Cholelithiasis (HP:0001081) | 1.85398428 |
106 | Hip contracture (HP:0003273) | 1.84442065 |
107 | Onion bulb formation (HP:0003383) | 1.84267609 |
108 | Hyperthyroidism (HP:0000836) | 1.84230336 |
109 | Poikilocytosis (HP:0004447) | 1.83977965 |
110 | Difficulty climbing stairs (HP:0003551) | 1.83229817 |
111 | Rimmed vacuoles (HP:0003805) | 1.82912828 |
112 | Muscular dystrophy (HP:0003560) | 1.81687171 |
113 | Weak cry (HP:0001612) | 1.80140792 |
114 | Abnormal gallbladder morphology (HP:0012437) | 1.79771486 |
115 | Large for gestational age (HP:0001520) | 1.78311208 |
116 | Cerebral edema (HP:0002181) | 1.76394084 |
117 | Abnormal auditory evoked potentials (HP:0006958) | 1.74050848 |
118 | Bulbar palsy (HP:0001283) | 1.73219421 |
119 | Hypoplastic heart (HP:0001961) | 1.72941727 |
120 | EMG: neuropathic changes (HP:0003445) | 1.72811534 |
121 | Peripheral hypomyelination (HP:0007182) | 1.72622735 |
122 | Increased intramyocellular lipid droplets (HP:0012240) | 1.71887173 |
123 | Distal lower limb amyotrophy (HP:0008944) | 1.71770835 |
124 | Dysmetric saccades (HP:0000641) | 1.71641926 |
125 | Generalized muscle weakness (HP:0003324) | 1.69981172 |
126 | Lactic acidosis (HP:0003128) | 1.69966254 |
127 | Abnormality of the corticospinal tract (HP:0002492) | 1.69678157 |
128 | Sensory axonal neuropathy (HP:0003390) | 1.68903357 |
129 | Limb-girdle muscle atrophy (HP:0003797) | 1.67233154 |
130 | Progressive muscle weakness (HP:0003323) | 1.66574700 |
131 | Paralysis (HP:0003470) | 1.57786680 |
132 | Febrile seizures (HP:0002373) | 1.56343189 |
133 | Increased muscle lipid content (HP:0009058) | 1.55161082 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 5.04968328 |
2 | STK39 | 4.05804722 |
3 | PHKG1 | 3.73791389 |
4 | PHKG2 | 3.73791389 |
5 | TTN | 3.01528919 |
6 | MYLK | 2.63082424 |
7 | MUSK | 2.32191048 |
8 | WNK4 | 2.31625015 |
9 | LMTK2 | 2.29182739 |
10 | OXSR1 | 2.19890514 |
11 | FRK | 2.13631414 |
12 | PKN1 | 2.13477369 |
13 | DMPK | 2.08898423 |
14 | PINK1 | 2.03574888 |
15 | LIMK1 | 1.99932037 |
16 | PIK3CA | 1.96354457 |
17 | PRPF4B | 1.88980094 |
18 | WNK1 | 1.87613583 |
19 | EPHB1 | 1.78164950 |
20 | STK24 | 1.76512395 |
21 | CAMK2D | 1.73864736 |
22 | PDK4 | 1.70174749 |
23 | PDK3 | 1.70174749 |
24 | DAPK2 | 1.68313540 |
25 | MARK1 | 1.67634460 |
26 | GRK7 | 1.63826166 |
27 | BCR | 1.62647303 |
28 | CASK | 1.51204313 |
29 | NTRK1 | 1.38428600 |
30 | INSRR | 1.32397058 |
31 | PAK3 | 1.28053102 |
32 | ZAK | 1.25909061 |
33 | UHMK1 | 1.23173812 |
34 | TIE1 | 1.21690852 |
35 | ROCK2 | 1.18604438 |
36 | NME1 | 1.18590096 |
37 | PDK2 | 1.17701967 |
38 | CAMK2B | 1.14066561 |
39 | CAMK2A | 1.13223230 |
40 | MET | 1.11264738 |
41 | SGK494 | 1.10683235 |
42 | SGK223 | 1.10683235 |
43 | MAPKAPK3 | 1.09872744 |
44 | PRKD1 | 1.09384270 |
45 | CAMK2G | 1.06498159 |
46 | CDC42BPA | 1.03108165 |
47 | SGK3 | 1.01522417 |
48 | MAP3K9 | 1.01060732 |
49 | CDK19 | 0.98071309 |
50 | MAP2K4 | 0.95325085 |
51 | PRKCE | 0.91989765 |
52 | ILK | 0.91300258 |
53 | MAP3K2 | 0.91288229 |
54 | MAP2K3 | 0.88540442 |
55 | DAPK3 | 0.86524356 |
56 | EPHA4 | 0.85554392 |
57 | PTK2B | 0.82604263 |
58 | EIF2AK1 | 0.81574404 |
59 | TAOK1 | 0.81161620 |
60 | DDR2 | 0.79965115 |
61 | PAK6 | 0.79043473 |
62 | NEK6 | 0.78612705 |
63 | FGFR3 | 0.78310724 |
64 | ROCK1 | 0.78053600 |
65 | BCKDK | 0.77705388 |
66 | MAP2K6 | 0.74611416 |
67 | MAPK12 | 0.74343058 |
68 | MAPKAPK5 | 0.73694317 |
69 | PRKD3 | 0.71560765 |
70 | MAP2K1 | 0.71356910 |
71 | PDPK1 | 0.70715277 |
72 | MAP3K7 | 0.65624931 |
73 | PRKACB | 0.62295381 |
74 | NTRK3 | 0.61161467 |
75 | CDK5 | 0.60544109 |
76 | STK4 | 0.59760741 |
77 | ERBB3 | 0.58990504 |
78 | NLK | 0.58687984 |
79 | PRKG1 | 0.57767736 |
80 | PRKACA | 0.56000473 |
81 | STK38L | 0.55800621 |
82 | CCNB1 | 0.55484736 |
83 | AKT2 | 0.55366282 |
84 | PRKAA1 | 0.52471584 |
85 | PBK | 0.52048504 |
86 | KSR2 | 0.51015189 |
87 | ARAF | 0.50966295 |
88 | KSR1 | 0.50795929 |
89 | GRK5 | 0.50669929 |
90 | AKT3 | 0.50400664 |
91 | PRKCH | 0.49568178 |
92 | HIPK2 | 0.49564775 |
93 | CSNK1G3 | 0.49018478 |
94 | CSNK1A1L | 0.48702364 |
95 | RPS6KA3 | 0.48473246 |
96 | MAPK4 | 0.48398387 |
97 | MAP3K5 | 0.48323185 |
98 | EEF2K | 0.48198401 |
99 | PRKCQ | 0.48012178 |
100 | MAPK7 | 0.45666882 |
101 | NEK1 | 0.45501099 |
102 | PRKAA2 | 0.45369974 |
103 | CAMK1 | 0.44790607 |
104 | PDK1 | 0.44261471 |
105 | MARK3 | 0.42636999 |
106 | RET | 0.42518887 |
107 | PLK2 | 0.41724983 |
108 | MAPK10 | 0.41402578 |
109 | SGK1 | 0.40957896 |
110 | MOS | 0.39367598 |
111 | RIPK1 | 0.38593153 |
112 | MAPK13 | 0.37630636 |
113 | RIPK4 | 0.36644284 |
114 | NTRK2 | 0.35887789 |
115 | MAP3K4 | 0.35371558 |
116 | CSNK1G2 | 0.35224158 |
117 | MAP3K6 | 0.35023910 |
118 | BMPR2 | 0.34973673 |
119 | CDK14 | 0.34179582 |
120 | FGFR2 | 0.33892435 |
121 | RAF1 | 0.33377695 |
122 | DYRK1A | 0.33279120 |
123 | MAPK11 | 0.33236751 |
124 | TNIK | 0.32526202 |
125 | MAP2K7 | 0.32433346 |
126 | PIK3CG | 0.31888454 |
127 | EPHA3 | 0.30812472 |
128 | MARK2 | 0.30130914 |
129 | CAMK4 | 0.28421997 |
130 | MAP3K13 | 0.27273939 |
131 | ICK | 0.26751281 |
132 | SGK2 | 0.26428574 |
133 | MAPK15 | 0.26028922 |
134 | CSNK1G1 | 0.25546076 |
135 | MAP3K1 | 0.25518724 |
136 | PRKACG | 0.25508160 |
137 | STK11 | 0.25115032 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.47898002 |
2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.93885015 |
3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.70328522 |
4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.43083013 |
5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.31705580 |
6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.26033492 |
7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.91981033 |
8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.39903203 |
9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.28913364 |
10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.20908645 |
11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.19588442 |
12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.14398620 |
13 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.08063846 |
14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80944065 |
15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.65582505 |
16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.59466361 |
17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54034827 |
18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.46554082 |
19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.26393228 |
20 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.24120021 |
21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.23780336 |
22 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.20825000 |
23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20693524 |
24 | Tight junction_Homo sapiens_hsa04530 | 1.19569005 |
25 | Olfactory transduction_Homo sapiens_hsa04740 | 1.16705401 |
26 | Insulin secretion_Homo sapiens_hsa04911 | 1.15554886 |
27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.11623169 |
28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.10319996 |
29 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.06460213 |
30 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06110933 |
31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.04792033 |
32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03770952 |
33 | Taste transduction_Homo sapiens_hsa04742 | 1.03463959 |
34 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03231722 |
35 | Morphine addiction_Homo sapiens_hsa05032 | 1.01980283 |
36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.01277895 |
37 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99832624 |
38 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.99532136 |
39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98856884 |
40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98602553 |
41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.98251833 |
42 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.98186671 |
43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.98096923 |
44 | GABAergic synapse_Homo sapiens_hsa04727 | 0.97164821 |
45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.96886091 |
46 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.95675148 |
47 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.94601158 |
48 | Renin secretion_Homo sapiens_hsa04924 | 0.94362283 |
49 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.90043872 |
50 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.86979909 |
51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.84506047 |
52 | Axon guidance_Homo sapiens_hsa04360 | 0.84337853 |
53 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.80874076 |
54 | Salivary secretion_Homo sapiens_hsa04970 | 0.80802311 |
55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79660460 |
56 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.78982713 |
57 | Protein export_Homo sapiens_hsa03060 | 0.76061541 |
58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75246913 |
59 | Long-term potentiation_Homo sapiens_hsa04720 | 0.75065092 |
60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74101359 |
61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73731103 |
62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71530791 |
63 | Bile secretion_Homo sapiens_hsa04976 | 0.71121250 |
64 | Phototransduction_Homo sapiens_hsa04744 | 0.68347371 |
65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67299514 |
66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66819102 |
67 | Long-term depression_Homo sapiens_hsa04730 | 0.66337714 |
68 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65654124 |
69 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64818757 |
70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63295157 |
71 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.63256352 |
72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62874438 |
73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62630649 |
74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62171315 |
75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62152488 |
76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61981374 |
77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61344083 |
78 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61228213 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61001500 |
80 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60672174 |
81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59329617 |
82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58902792 |
83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58807573 |
84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58472363 |
85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57936756 |
86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57737482 |
87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57681773 |
88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55051891 |
89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54591258 |
90 | Gap junction_Homo sapiens_hsa04540 | 0.54499158 |
91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52570005 |
92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.52370122 |
93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51764635 |
94 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51622291 |
95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51521485 |
96 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.50739378 |
97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50595649 |
98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50507262 |
99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50098827 |
100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49695303 |
101 | Melanogenesis_Homo sapiens_hsa04916 | 0.49161067 |
102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48847801 |
103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47797883 |
104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47399761 |
105 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47006471 |
106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46687409 |
107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44899394 |
108 | Focal adhesion_Homo sapiens_hsa04510 | 0.44672255 |
109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43791736 |
110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43331347 |
111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42892457 |
112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41924449 |
113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39958052 |
114 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39226728 |
115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39151751 |
116 | Insulin resistance_Homo sapiens_hsa04931 | 0.38749257 |
117 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38064255 |
118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37275800 |
119 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37133541 |
120 | Nicotine addiction_Homo sapiens_hsa05033 | 0.35857337 |
121 | Peroxisome_Homo sapiens_hsa04146 | 0.35664270 |
122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35386595 |
123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34967234 |
124 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34402346 |
125 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.34393841 |
126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31260178 |
127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30546327 |